Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Noahm Inc. manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is 1 pending office action currently on file for the company. This single active case suggests a specific focus on a particular biological or pharmaceutical advancement. The current prosecution volume indicates a highly targeted approach to intellectual property protection in the life sciences sector.
The prosecution process is confined to a distinct examiner and 1 distinct art unit. This indicates that the technology is being reviewed by a specialized division of the patent office. ALANA HARRIS DENT is the busiest examiner, currently overseeing the busiest examiner pending office action. This examiner is the sole individual responsible for the company's current pending matters, which allows for a more direct and consistent technical exchange.
The presence of 1 distinct art unit and the pending office action suggests a low level of administrative complexity. Practitioners can focus their resources on addressing the specific technical issues raised by ALANA HARRIS DENT. Success in this matter will determine the current progress of the portfolio within the Biotechnology & Pharmaceuticals field, making the relationship with this specific examiner the central focus of the company's immediate patent strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DENT, ALANA HARRIS | 1 | 44.1% | +32.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17419634 | ANTICANCER COMPOSITIONS COMPRISING IMMUNE CHECKPOINT INHIBITORS | DENT, ALANA HARRIS | 50d overdue |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17419634 | ANTICANCER COMPOSITIONS COMPRISING IMMUNE CHECKPOINT INHIBITORS | DENT, ALANA HARRIS | 1643 | §103 | Final Rejection | 50d overdue | Pending | Jun 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNoahm Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Alana Harris Dent has the most, with 1 of Noahm Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
